These findings indicate that while pemetrexed could only exert minor cytotoxic effects on tumor cells, pemetrexed-induced PD-L1 upregulation plus the subsequent PD-1/PD-L1 blockade could sensitize tumor cells to the T cell-mediated tumor cell killing. This evidence concerns the gene CD274 and neoplasm.